<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37255928</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2633-6960</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Oxford open immunology</Title><ISOAbbreviation>Oxf Open Immunol</ISOAbbreviation></Journal><ArticleTitle>Autoimmunity in Long Covid and POTS.</ArticleTitle><Pagination><StartPage>iqad002</StartPage><MedlinePgn>iqad002</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">iqad002</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/oxfimm/iqad002</ELocationID><Abstract><AbstractText>Orthostatic intolerance and other autonomic dysfunction syndromes are emerging as distinct symptom clusters in Long Covid. Often accompanying these are common, multi-system constitutional features such as fatigue, malaise and skin rashes which can signify generalized immune dysregulation. At the same time, multiple autoantibodies are identified in both Covid-related autonomic disorders and non-Covid autonomic disorders, implying a possible underlying autoimmune pathology. The lack of specificity of these findings precludes direct interpretations of cause and association, but their prevalence with its supporting evidence is compelling.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El-Rhermoul</LastName><ForeName>Fatema-Zahra</ForeName><Initials>FZ</Initials><AffiliationInfo><Affiliation>Department of Allergy and Clinical Immunology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fedorowski</LastName><ForeName>Artur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Karolinska University Hospital and Karolinska Institute, Stockholm 171 77, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eardley</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Imperial Syncope Unit, Imperial College Healthcare NHS Trust, London W12 0HS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taraborrelli</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Imperial Syncope Unit, Imperial College Healthcare NHS Trust, London W12 0HS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagopoulos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Imperial Syncope Unit, Imperial College Healthcare NHS Trust, London W12 0HS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutton</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London SW3 6LY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Phang Boon</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Imperial Syncope Unit, Imperial College Healthcare NHS Trust, London W12 0HS, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dani</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5113-7248</Identifier><AffiliationInfo><Affiliation>Imperial Syncope Unit, Imperial College Healthcare NHS Trust, London W12 0HS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cutrale Perioperative and Ageing Group, Department of Bioengineering, Imperial College London, London W12 0BZ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Oxf Open Immunol</MedlineTA><NlmUniqueID>101770669</NlmUniqueID><ISSNLinking>2633-6960</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">POTS</Keyword><Keyword MajorTopicYN="N">autoantibody</Keyword><Keyword MajorTopicYN="N">autoimmune</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword></KeywordList><CoiStatement>The authors do not declare any conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37255928</ArticleId><ArticleId IdType="pmc">PMC10224806</ArticleId><ArticleId IdType="doi">10.1093/oxfimm/iqad002</ArticleId><ArticleId IdType="pii">iqad002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kioussis D, Pachnis V.. Immune and nervous systems: more than just a superficial similarity? Immunity, 2009;31:705&#x2013;10. 10.1016/j.immuni.2009.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.09.009</ArticleId><ArticleId IdType="pubmed">19836266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney MJ, Ganta CK.. Autonomic nervous system and immune system interactions. Compr Physiol 2014;4:1177&#x2013;200. 10.1002/cphy.c130051</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c130051</ArticleId><ArticleId IdType="pmc">PMC4374437</ArticleId><ArticleId IdType="pubmed">24944034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma D, David Farrar J.. Adrenergic regulation of immune cell function and inflammation. Semin Immunopathol 2020;42:709717. 10.1007/s00281-020-00829-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-020-00829-6</ArticleId><ArticleId IdType="pmc">PMC7678770</ArticleId><ArticleId IdType="pubmed">33219396</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Mashimo M, Moriwaki Y. et al. Expression and function of the cholinergic system in immune cells. Front Immunol 2017;8:1085. 10.3389/fimmu.2017.01085</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01085</ArticleId><ArticleId IdType="pmc">PMC5592202</ArticleId><ArticleId IdType="pubmed">28932225</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig MF, Powell M, Staedtke V. et al. Preventing cytokine storm syndrome in COVID-19 using &#x3b1;-1 adrenergic receptor antagonists. J Clin Investig 2020;130:3345&#x2013;7. 10.1172/JCI139642</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139642</ArticleId><ArticleId IdType="pmc">PMC7324164</ArticleId><ArticleId IdType="pubmed">32352407</ArticleId></ArticleIdList></Reference><Reference><Citation>Staedtke V, Bai RY, Kim K. et al. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature 2018;564:273&#x2013;7. 10.1038/s41586-018-0774-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0774-y</ArticleId><ArticleId IdType="pmc">PMC6512810</ArticleId><ArticleId IdType="pubmed">30542164</ArticleId></ArticleIdList></Reference><Reference><Citation>Porzionato A, Emmi A, Barbon S. et al. Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J 2020;287:3681&#x2013;8. 10.1111/febs.15481</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15481</ArticleId><ArticleId IdType="pmc">PMC7405290</ArticleId><ArticleId IdType="pubmed">32779891</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res 2020;30:299&#x2013;315. 10.1007/s10286-020-00714-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00714-0</ArticleId><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio R, Marcus NJ, Inestrosa NC.. Potential role of autonomic dysfunction in Covid-19 morbidity and mortality. Front Physiol 2020;11: 561749. 10.3389/fphys.2020.561749</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.561749</ArticleId><ArticleId IdType="pmc">PMC7597395</ArticleId><ArticleId IdType="pubmed">33178034</ArticleId></ArticleIdList></Reference><Reference><Citation>Tornero C, Pastor E, Garzando MDM. et al. Non-invasive vagus nerve stimulation for COVID-19: results from a randomized controlled trial (SAVIOR I). Front Neurol 2022;13:820864. 10.3389/fneur.2022.820864</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.820864</ArticleId><ArticleId IdType="pmc">PMC9028764</ArticleId><ArticleId IdType="pubmed">35463130</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K. et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 2021;4:100100. 10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning iii WT, Kvale H, Kramer PM. et al. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies. J Am Heart Assoc 2019;8:e013602. 10.1161/JAHA.119.013602</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.013602</ArticleId><ArticleId IdType="pmc">PMC6818019</ArticleId><ArticleId IdType="pubmed">31495251</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O, Halpert G, Schimke LF. et al. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun 2022;13:1220. 10.1038/s41467-022-28905-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId><ArticleId IdType="pmc">PMC8907309</ArticleId><ArticleId IdType="pubmed">35264564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 2021;595:283&#x2013;8. 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Nagy B, R&#xe1;duly AP. et al. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Geroscience 2022, 10.1007/s11357-022-00649-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00649-6</ArticleId><ArticleId IdType="pmc">PMC9483490</ArticleId><ArticleId IdType="pubmed">36112333</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M. et al. Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis 2022;225:2155&#x2013;62. 10.1093/infdis/jiac017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022;23:210&#x2013;6. 10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A. et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. Eur Respir J 2023;61:2200970. 10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 6 May 2022. Office of National Statistics, 2022.</Citation></Reference><Reference><Citation>NICE, RCGP, and SIGN. Covid-19 rapid guideline: managing the long-term effects of COVID-19; 2020. https://www./nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertin D, Kaphan E, Weber S. et al. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome. Int J Infect Dis 2021;113:23&#x2013;5. 10.1016/j.ijid.2021.09.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.079</ArticleId><ArticleId IdType="pmc">PMC8487460</ArticleId><ArticleId IdType="pubmed">34614444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingel H, Meltendorf S, Billing U. et al. Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals. J Autoimmun 2021;122:102682. 10.1016/j.jaut.2021.102682</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102682</ArticleId><ArticleId IdType="pmc">PMC8214939</ArticleId><ArticleId IdType="pubmed">34214763</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascolini S, Vannini A, Deleonardi G. et al. COVID-19 and immunological dysregulation: can autoantibodies be useful? Clin Transl Sci 2021;14:502&#x2013;8. 10.1111/cts.12908</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12908</ArticleId><ArticleId IdType="pmc">PMC7536986</ArticleId><ArticleId IdType="pubmed">32989903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Cao S, Lee AS. et al. Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome. JCI Insight 2022;7:e156713. 10.1172/jci</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci</ArticleId><ArticleId IdType="pmc">PMC9310538</ArticleId><ArticleId IdType="pubmed">35801588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y. et al. Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med 2022;20:129. 10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Mitchell A, Yu Wang C. et al. Low prevalence of interferon-&#x3b1; autoantibodies in people experiencing long COVID 1 symptoms 2. J Infect Dis 2023;227:246&#x2013;50. 10.1093/infdis/jiac372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac372</ArticleId><ArticleId IdType="pmc">PMC9494362</ArticleId><ArticleId IdType="pubmed">36089700</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C, Mardin C, Lucio M. et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int J Mol Sci 2022;23:7209. 10.3390/ijms23137209</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881&#x2013;895.e20. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahabi S, Hassan ZM, Jazani NH. et al. Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 2006;67:900&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16806730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J 2022;59:2102245. 10.1183/13993003.02245-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch EE. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc 2012;87:1214&#x2013;25. 10.1016/j.mayocp.2012.08.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.08.013</ArticleId><ArticleId IdType="pmc">PMC3547546</ArticleId><ArticleId IdType="pubmed">23122672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon RS, Grubb BP, Olshansky B. et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015;12:e41&#x2013;e63. 10.1016/j.hrthm.2015.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2015.03.029</ArticleId><ArticleId IdType="pmc">PMC5267948</ArticleId><ArticleId IdType="pubmed">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P. et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med 2021;21:E63&#x2013;7. 10.7861/CLINMED.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/CLINMED.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Seliger J, Shaik R. et al. A case series of cutaneous phosphorylated &#x3b1;-synuclein in long-COVID POTS. Clin Auton Res 2022, 10.1007/s10286-022-00867-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-022-00867-0</ArticleId><ArticleId IdType="pmc">PMC9108014</ArticleId><ArticleId IdType="pubmed">35570247</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R. et al. A case report of postural tachycardia syndrome after Covid-19. Clin Auton Res 2020;30:449&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A. et al. Long-COVID postural tachycardia syndrome: an American autonomic society statement. Clin Auton Res 2021;31:365&#x2013;8. 10.1007/s10286-021-00798-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP. et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res 2021;31:385&#x2013;94. 10.1007/s10286-021-00803-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S.. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res 2021;69:205&#x2013;11. 10.1007/s12026-021-09185-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Drogalis-Kim D, Kramer C, Duran S.. Ongoing dizziness following acute COVID-19 infection: a single center pediatric case series. Pediatrics 2022;150:e2022056860. 10.1542/peds.2022-056860</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-056860</ArticleId><ArticleId IdType="pubmed">35642018</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal SM, Landers DB, Hollenberg SM. et al. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol 2022;79:2325&#x2013;30. 10.1016/j.jacc.2022.03.357</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA. et al. Autonomic dysfunction in post-COVID patients with and without neurological symptoms: a prospective multidomain observational study. J Neurol 2022;269:587&#x2013;96. 10.1007/s00415-021-10735-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen CMC, Rowe PC, Visser FC.. Orthostatic symptoms and reductions in cerebral blood flow in long-haul covid-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina (Lithuania )2022;58:28. 10.3390/medicina58010028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus 2015;24:1364&#x2013;9. 10.1177/0961203315587566</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315587566</ArticleId><ArticleId IdType="pubmed">26038344</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sutton R.
Diagnostic tools to assess dysfunction of autonomic control of the heart corresponding author. J Atr Fibrillation 2020;13:66&#x2013;73. www.jafib.com</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533133</ArticleId><ArticleId IdType="pubmed">33024502</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer F, Ginsberg JP.. An overview of heart rate variability metrics and norms. Front Public Health 2017;5:258. 10.3389/fpubh.2017.00258</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2017.00258</ArticleId><ArticleId IdType="pmc">PMC5624990</ArticleId><ArticleId IdType="pubmed">29034226</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B, Kunal S, Bansal A. et al. Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence. Indian Pacing Electrophysiol J 2022;22:70&#x2013;6. 10.1016/j.ipej.2022.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ipej.2022.01.004</ArticleId><ArticleId IdType="pmc">PMC8800539</ArticleId><ArticleId IdType="pubmed">35101582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurto&#x11f;lu E, Afsin A, Akta&#x15f; &#x130;. et al. Altered cardiac autonomic function after recovery from COVID-19. Ann Noninvasive Electrocardiol 2022;27:e12916. 10.1111/anec.12916</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12916</ArticleId><ArticleId IdType="pmc">PMC8739610</ArticleId><ArticleId IdType="pubmed">34817120</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloberti A, Ughi N, Bernasconi DP. et al. Heart rate in patients with SARS-CoV-2 infection: prevalence of high values at discharge and relationship with disease severity. J Clin Med 2021;10:5590. 10.3390/jcm10235590</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10235590</ArticleId><ArticleId IdType="pmc">PMC8658577</ArticleId><ArticleId IdType="pubmed">34884293</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanoli J, Marro G, Dell&#x2019;Oro R. et al. Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19. Cardiol J 2022, 29(2):181-187. 10.5603/CJ.a2022.0009</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/CJ.a2022.0009</ArticleId><ArticleId IdType="pmc">PMC9007487</ArticleId><ArticleId IdType="pubmed">35244197</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol MBA, Strous MTA, van Osch FHM. et al. Heart-rate-variability (HRV), predicts outcomes in COVID-19. PLoS ONE 2021;16:e0258841. 10.1371/journal.pone.0258841</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258841</ArticleId><ArticleId IdType="pmc">PMC8553073</ArticleId><ArticleId IdType="pubmed">34710127</ArticleId></ArticleIdList></Reference><Reference><Citation>Stute NL, Stickford JL, Province VM. et al. COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2. J Physiol 2021;599:4269&#x2013;85. 10.1113/JP281888#support-information-section</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP281888#support-information-section</ArticleId><ArticleId IdType="pmc">PMC8447023</ArticleId><ArticleId IdType="pubmed">34174086</ArticleId></ArticleIdList></Reference><Reference><Citation>Freire APCF, Lira FS, von Ah Morano AE. et al. Role of body mass and physical activity in autonomic function modulation on post-COVID-19 condition: an observational subanalysis of fit-COVID study. Int J Environ Res Public Health 2022;19:2457. 10.3390/ijerph19042457</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19042457</ArticleId><ArticleId IdType="pmc">PMC8875183</ArticleId><ArticleId IdType="pubmed">35206647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai T, Zhou D, Yushanjiang F. et al. Alternation of the autonomic nervous system is associated with pulmonary sequelae in patients with COVID-19 after six months of discharge. Front Physiol 2022;12:805925. 10.3389/fphys.2021.805925</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.805925</ArticleId><ArticleId IdType="pmc">PMC8814436</ArticleId><ArticleId IdType="pubmed">35126184</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Melander O.. Syndromes of orthostatic intolerance: a hidden danger. J Intern Med 2013;273:322&#x2013;35. 10.1111/joim.12021</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12021</ArticleId><ArticleId IdType="pubmed">23216860</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardine DL, Wieling W, Brignole M. et al. The pathophysiology of the vasovagal response. Heart Rhythm 2018;15:921&#x2013;9. 10.1016/j.hrthm.2017.12.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2017.12.013</ArticleId><ArticleId IdType="pmc">PMC5984661</ArticleId><ArticleId IdType="pubmed">29246828</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, Stiles LE, Bourne K. et al. The face of postural tachycardia syndrome&#x2014;insights from a large cross-sectional online community-based survey. J Intern Med 2019;286:438&#x2013;48. 10.1111/joim.12895</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno R, Cannom DS, Olshansky B. et al. Mast cell activation disorder and postural orthostatic tachycardia syndrome: a clinical association. J Am Heart Assoc 2021;10:e0211002. 10.1161/JAHA.121.021002</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.021002</ArticleId><ArticleId IdType="pmc">PMC8649306</ArticleId><ArticleId IdType="pubmed">34398691</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahic JM, Hamrefors V, Johansson M. et al. Malm&#xf6; POTS symptom score: assessing symptom burden in postural orthostatic tachycardia syndrome. J Intern Med 2023;293:91&#x2013;99. 10.1111/joim.13566</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13566</ArticleId><ArticleId IdType="pmc">PMC10087729</ArticleId><ArticleId IdType="pubmed">36111700</ArticleId></ArticleIdList></Reference><Reference><Citation>Olshansky B, Cannom D, Fedorowski A. et al. Postural orthostatic tachycardia syndrome (POTS): a critical assessment. Prog Cardiovasc Dis 2020;63:263&#x2013;70. 10.1016/j.pcad.2020.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.03.010</ArticleId><ArticleId IdType="pmc">PMC9012474</ArticleId><ArticleId IdType="pubmed">32222376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting&#x2014;Part 1. Auton Neurosci 2021;235:102828. doi 10.1016/j.autneu.2021.102828</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny HA, Aziz I, Ferrar M. et al. Is there a relationship between gluten sensitivity and postural tachycardia syndrome? Eur J Gastroenterol Hepatol 2016:1383&#x2013;87, 10.1097/MEG.0000000000000740</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000000740</ArticleId><ArticleId IdType="pubmed">27606948</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman BP, Crepeau A, Dhawan PS. et al. Spectrum of autonomic nervous system impairment in Sj&#xf6;gren syndrome. Neurologist 2017;22:127&#x2013;30. 10.1097/NRL.0000000000000134</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NRL.0000000000000134</ArticleId><ArticleId IdType="pubmed">28644253</ArticleId></ArticleIdList></Reference><Reference><Citation>Thieben MJ, Sandroni P, Sletten DM. et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc 2007;82:308&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352367</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina V, Shoenfeld Y.. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005;38:235&#x2013;45. 10.1080/08916930500050277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500050277</ArticleId><ArticleId IdType="pubmed">16126512</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahic JM, Ricci F, Aung N. et al. Proconvertase furin is down regulated in postural orthostatic tachycardia syndrome. Front Neurosci 2019;13:301. 10.3389/fnins.2019.00301</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6455076</ArticleId><ArticleId IdType="pubmed">31001074</ArticleId></ArticleIdList></Reference><Reference><Citation>Medic Spahic J, Ricci F, Aung N. et al. Proteomic analysis reveals sex-specific biomarker signature in postural orthostatic tachycardia syndrome. BMC Cardiovasc Disord 2020;20:190. 10.1186/s12872-020-01465-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-020-01465-6</ArticleId><ArticleId IdType="pmc">PMC7178975</ArticleId><ArticleId IdType="pubmed">32321428</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, Yan H, Welinder C. et al. Proteomic profiling in postural orthostatic tachycardia syndrome reveals new disease pathways. Sci Rep 2022;12:20051. 10.1038/s41598-022-24729-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24729-x</ArticleId><ArticleId IdType="pmc">PMC9681882</ArticleId><ArticleId IdType="pubmed">36414707</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H, Fang F, Tomasson G. et al. Association of stress-related disorders with subsequent autoimmune disease. JAMA 2018;319:2388&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583688</ArticleId><ArticleId IdType="pubmed">29922828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy B, Valdimarsd&#xf3;ttir U, Sundstr&#xf6;m K. et al. Loss of a parent and the risk of cancer in early life: a nationwide cohort study. Cancer Causes Control 2014;25:499&#x2013;506. 10.1007/s10552-014-0352-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10552-014-0352-z</ArticleId><ArticleId IdType="pubmed">24500176</ArticleId></ArticleIdList></Reference><Reference><Citation>Steptoe A, Kivim&#xe4;ki M.. Stress and cardiovascular disease. Nat Rev Cardiol 2012;9:360&#x2013;70. 10.1038/nrcardio.2012.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2012.45</ArticleId><ArticleId IdType="pubmed">22473079</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J. et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci 2022;434:120162. 10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JW, Lambert EA, Sari CI. et al. Cognitive function, health-related quality of life, and symptoms of depression and anxiety sensitivity are impaired in patients with the postural orthostatic tachycardia syndrome (POTS). Front Physiol 2014;5:230. 10.3389/fphys.2014.00230</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00230</ArticleId><ArticleId IdType="pmc">PMC4070177</ArticleId><ArticleId IdType="pubmed">25009504</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens AP, Low DA, Critchley HD. et al. Emotional orienting during interoceptive threat in orthostatic intolerance: dysautonomic contributions to psychological symptomatology in the postural tachycardia syndrome and vasovagal syncope. Auton Neurosci 2018;212:42&#x2013;7. 10.1016/j.autneu.2018.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.01.004</ArticleId><ArticleId IdType="pubmed">29519640</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens AP, Low DA, Iodice V. et al. The genesis and presentation of anxiety in disorders of autonomic overexcitation. Auton Neurosci 2017;203:81&#x2013;7. 10.1016/j.autneu.2016.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2016.10.004</ArticleId><ArticleId IdType="pubmed">27865628</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Li H, Yu X. et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace 2017;19:1211&#x2013;9. 10.1093/europace/euw154</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euw154</ArticleId><ArticleId IdType="pmc">PMC5834103</ArticleId><ArticleId IdType="pubmed">27702852</ArticleId></ArticleIdList></Reference><Reference><Citation>Watari M, Nakane S, Mukaino A. et al. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol 2018;5:486&#x2013;92. 10.1002/acn3.524</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.524</ArticleId><ArticleId IdType="pmc">PMC5899914</ArticleId><ArticleId IdType="pubmed">29687025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M, Batizy L, Dasa O. et al. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scan Cardiovasc J 2017;51:243&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28738696</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Yu X, Liles C. et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc 2014;3:e000755. 10.1161/JAHA.113.000755</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000755</ArticleId><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunami Y, Sugaya K, Miyakoshi N. et al. Association of autoantibodies to muscarinic acetylcholine receptors with gastrointestinal symptoms and disease severity in patients with postural orthostatic tachycardia syndrome. Immunol Res 2022;70:197&#x2013;207. 10.1007/s12026-021-09256-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09256-7</ArticleId><ArticleId IdType="pubmed">34993884</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S. et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med 2021;10:3675. 10.3390/jcm10163675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharraziha I, Axelsson J, Ricci F. et al. Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J Am Heart Assoc 2020;9:e015989. 10.1161/JAHA.120.015989</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.015989</ArticleId><ArticleId IdType="pmc">PMC7792263</ArticleId><ArticleId IdType="pubmed">32750291</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Stiles LE.. Autoimmunity in postural orthostatic tachycardia syndrome: current understanding. Auton Neurosci 2018;215:78&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">29909990</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiale PA, Garro HA, Schmidberg J. et al. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta adrenergic receptors. Heart Rhythm 2006;3:1182&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17018348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohr D, Singh P, Tschernatsch M. et al. Autoimmunity against the &#x3b2;-2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 2011;152:2690&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">21816540</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S. et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J Clin Med 2021;10:3675. 10.3390/jcm10163675</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ven E, Duus K, Lydolph MC et al.. Non-specific binding in solid phase immunoassays for autoantibodies correlates with inflammation markers. J Immunol Methods 2014;403:26&#x2013;36. 10.1016/j.jim.2013.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2013.11.014</ArticleId><ArticleId IdType="pubmed">24287423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J, Bourne KM, Vernino S. et al. Detection of G protein-coupled receptor autoantibodies in postural orthostatic tachycardia syndrome using standard methodology. Circulation 2022;146:613&#x2013;22. 10.1161/CIRCULATIONAHA.122.059971</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059971</ArticleId><ArticleId IdType="pmc">PMC9390234</ArticleId><ArticleId IdType="pubmed">35766055</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbelo PD, Lebovitz EE, Notkins AL.. Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases. Transl Res 2015;165:325&#x2013;35. 10.1016/j.trsl.2014.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2014.08.006</ArticleId><ArticleId IdType="pmc">PMC4306608</ArticleId><ArticleId IdType="pubmed">25241936</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS. et al. Mast cell activation symptoms are prevalent in long-COVID. Int J Infect Dis 2021;112:217&#x2013;26. 10.1016/j.ijid.2021.09.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler JB, Butuci M, Wong A. et al. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy: Eur J Allergy Clin Immunol 2022;77:1288&#x2013;91. 10.1111/all.15188</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Molderings GJ, Brettner S, Homann J. et al. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. J Hematol Oncol 2011;4:10. 10.1186/1756-8722-4-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-8722-4-10</ArticleId><ArticleId IdType="pmc">PMC3069946</ArticleId><ArticleId IdType="pubmed">21418662</ArticleId></ArticleIdList></Reference><Reference><Citation>Akin C, Valent P, Metcalfe DD.. Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol 2010;126:1099&#x2013;103. 10.1016/j.jaci.2010.08.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.08.035</ArticleId><ArticleId IdType="pmc">PMC3753019</ArticleId><ArticleId IdType="pubmed">21035176</ArticleId></ArticleIdList></Reference><Reference><Citation>Valent P, Akin C, Arock M. et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 2012;157:215&#x2013;25. 10.1159/000328760</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000328760</ArticleId><ArticleId IdType="pmc">PMC3224511</ArticleId><ArticleId IdType="pubmed">22041891</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Ackerley MB, Bluestein LS. et al. Diagnosis of mast cell activation syndrome: a global &#x201c;consensus-2.&#x201d; Diagnosis 2021;8:137&#x2013;52. 10.1515/dx-2020-0005</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2020-0005</ArticleId><ArticleId IdType="pubmed">32324159</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibao C, Arzubiaga C, Roberts LJ. et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 2005;45:385&#x2013;90. 10.1161/01.HYP.0000158259.68614.40</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000158259.68614.40</ArticleId><ArticleId IdType="pubmed">15710782</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V. et al. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med 2022;70:61&#x2013;7. 10.1136/jim-2021-002051</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci 2020;21:100276. 10.1016/j.ensci.2020.100276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100276</ArticleId><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Myers TL. et al. Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment. BMJ Case Rep 2018;2018:bcr2017221405. 10.1136/bcr-2017-221405</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2017-221405</ArticleId><ArticleId IdType="pmc">PMC5778345</ArticleId><ArticleId IdType="pubmed">29326369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Voit-Bak K, Donate T. et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol Psychiatry 2022;27:34&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>